Pull ten injectable charts from ten different med spas and you’ll find a wide range. Some read like proper clinical records. A surprising number read like receipts: “Botox 40u” with a date and a price. Both kinds of clinic believe they’re documenting their treatments. Only one of them is.
The gap usually isn’t laziness. It’s that nobody ever specified what a complete injectable record contains, so each injector charts whatever they’d personally want to know next time, and that varies by person and shrinks under time pressure. This post is the specification: what goes in the chart, why each piece earns its place, and how to capture it all without adding ten minutes to every appointment.
What a complete injectable record contains
For a neurotoxin or filler treatment, the chart should capture:
The assessment. Why this treatment, for this patient, today. Contraindications checked, relevant history reviewed, and, where the treatment is delegated, a reference to the order or medical directive it’s performed under. This is the piece that makes it a clinical record rather than a sales record.
The product, precisely. Brand, concentration, and for neurotoxin the dilution used. “Botox” alone doesn’t cut it when the clinic stocks two toxins and a patient later asks what they’ve had before.
Lot number and expiry. Every syringe traced back to the vial it came from. If a manufacturer flags a lot, the question “which patients received this” needs an answer measured in minutes. We’ve written about lot and expiry tracking from the inventory side; the chart is where that tracking pays off.
Units and sites. Not “40 units, upper face” but how many units in which muscle, per side. Facial diagrams work well here. So does a structured dose table. What doesn’t work is prose, because prose is where per-site detail goes to die. For dosing ranges by area, our Botox unit calculator shows the level of granularity a chart should match.
Who did what. The injector, and where relevant the authorizing prescriber. Obvious in a solo clinic. In a multi-injector clinic it seems obvious right up until someone leaves and two years of their charts turn ambiguous.
Photos. Before, and at follow-up, after. Taken consistently, attached to the visit they document, with photo consent on file. A filler chart without photos means arguing about swelling from memory.
The patient’s own report. Anything the patient raised, anything you told them to watch for, and the aftercare instructions given. When a patient calls on day three about asymmetry, the chart should already show what was discussed.
Why thin charts become expensive
A thin chart costs nothing on the day it’s written. The bill arrives later, in one of four envelopes.
Adverse events. A vascular occlusion during filler. Ptosis that shows up two days after a toxin appointment. The clinical response happens in the moment, but everything that follows depends on the record: what product, what lot, how much, where exactly. An incomplete chart turns a manageable complication into a defensibility problem.
Recalls. Lot-level product issues are rare but not theoretical. Clinics with lot numbers in their charts handle a recall with a query. Clinics without them handle it with a phone tree and hope.
Complaints and legal claims. Cosmetic treatment disputes often surface long after the appointment, sometimes years. The injector’s memory won’t be evidence. The chart will. Colleges reviewing an injector’s practice will read the charts first, and thin ones read badly regardless of how good the clinical care was.
Continuity. The mundane one, and the most frequent. A returning patient should never need to remember their own dose history. If your charts can’t tell a new injector exactly what the last injector did, every provider change resets the patient’s treatment from scratch.
Free text is where this falls apart
Most clinics that chart badly don’t lack a policy. They lack a format. When the chart is a blank text box, completeness depends on the injector’s discipline at 6pm on a fully booked Friday, and the units-per-site table is the first thing that gets abbreviated away.
The fix is structure. If the chart template has fields for product, lot, dilution, and a per-site dose table, filling it in is faster than typing prose, and skipping a field is visible instead of silent. That’s the design idea behind Zdrovia’s smart blocks: structured inputs for the parts of a treatment record that should never be free text, inside charting that still lets you write normally around them. Lot numbers pull from inventory at dispense time rather than being typed twice, which is also how they stay accurate.
It’s worth saying that structure serves the injector, not just the lawyer. A structured record from last visit means the next appointment starts with “same as last time, 24 units across the frontalis, here’s the map” instead of five minutes of chart archaeology.
A reasonable standard to hold yourself to
Here’s the test we’d suggest: could a competent injector who has never met the patient pick up the chart and safely repeat or adjust the last treatment? If yes, your documentation is doing its job. If they’d need to call the previous injector, or the patient, or guess, then the chart is a receipt with extra steps.
Getting there doesn’t require heroics. It requires a template that asks for the right fields and a system that makes filling them the path of least resistance. If you want to see what that looks like in practice, the med spa solution page covers the full charting workflow, and the core platform is free while in beta.